Founded by Genzyme Alumni, Cambridge's X4 Pharma Scores $27M Post author:Sam Post published:November 15, 2017 Post category:BioPharma X4 Pharma announced it had closed a $27M Series B financing. Source: BioSpace You Might Also Like Celgene's Multiple Myeloma Triplet Succeeds in Key Phase III Trial February 5, 2018 Esperion Stock Gains On Strong Phase II Data August 7, 2017 Nuritas Founder Wins Woman Of The Decade In Business And Leadership Award January 29, 2017
